Biodesix, Inc.
BDSX
$0.50
-$0.049-8.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 45.30% | 48.92% | 46.25% | 34.70% | 28.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.30% | 48.92% | 46.25% | 34.70% | 28.46% |
| Cost of Revenue | 19.70% | 12.85% | 2.32% | -7.61% | -8.08% |
| Gross Profit | 54.53% | 63.93% | 66.97% | 57.08% | 49.96% |
| SG&A Expenses | 19.39% | 12.87% | 6.80% | 4.53% | 9.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.81% | 8.39% | 0.66% | -2.63% | 1.88% |
| Operating Income | 17.04% | 28.51% | 36.00% | 31.60% | 18.23% |
| Income Before Tax | 17.67% | 30.82% | 32.66% | 31.37% | 20.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.67% | 30.82% | 32.66% | 31.37% | 20.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.67% | 30.82% | 32.66% | 31.37% | 20.32% |
| EBIT | 17.04% | 28.51% | 36.00% | 31.60% | 18.23% |
| EBITDA | 24.97% | 35.11% | 41.04% | 34.83% | 19.06% |
| EPS Basic | 45.67% | 56.19% | 58.09% | 59.03% | 59.45% |
| Normalized Basic EPS | 46.24% | 52.97% | 55.56% | 54.10% | 55.34% |
| EPS Diluted | 45.67% | 56.19% | 58.09% | 59.03% | 59.45% |
| Normalized Diluted EPS | 46.24% | 52.97% | 55.56% | 54.10% | 55.34% |
| Average Basic Shares Outstanding | 57.55% | 57.58% | 55.73% | 61.53% | 94.77% |
| Average Diluted Shares Outstanding | 57.55% | 57.58% | 55.73% | 61.53% | 94.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |